Heptabarb

Heptabarb
Clinical data
Other names	G-475
Routes of; administration	Oral
ATC code	N05CA11 (WHO) ;
Legal status
Legal status	CA: Schedule IV;
Pharmacokinetic data
Bioavailability	83%
Metabolism	Hepatic
Elimination half-life	6.1-11.2 hours
Excretion	Renal
Identifiers
	IUPAC name 5-cyclohept-1-en-1-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	509-86-4;
PubChem CID	10518;
DrugBank	DB01354 ;
ChemSpider	10081 ;
UNII	V10R70ML23;
KEGG	C17725 ;
ChEMBL	ChEMBL468837 ;
CompTox Dashboard (EPA)	DTXSID10198927 ;
ECHA InfoCard	100.007.371
Chemical and physical data
Formula	C13H18N2O3
Molar mass	250.298 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1NC(=O)NC(=O)C1(/C2=C/CCCCC2)CC;
	InChI InChI=1S/C13H18N2O3/c1-2-13(9-7-5-3-4-6-8-9)10(16)14-12(18)15-11(13)17/h7H,2-6,8H2,1H3,(H2,14,15,16,17,18) ; Key:PAZQYDJGLKSCSI-UHFFFAOYSA-N ;
	(verify)

Heptabarb (INN; Eudan, Medapan, Medomin, Noctyn), also known as heptabarbitone (BAN) or heptabarbital, is a sedative and hypnotic drug of the barbiturate family.^[2]^[3] It was used in Europe for the treatment of insomnia from the 1950s onwards, but has since been discontinued.^[2]^[3]

References

^ ^a ^b ^c ^d Breimer DD, de Boer AG (December 1975). "Pharmacokinetics and relative bioavailability of heptabarbital and heptabarbital sodium after oral administration to man". European Journal of Clinical Pharmacology. 9 (2–3): 169–78. doi:10.1007/bf00614014. PMID 9299. S2CID 32380531.
^ ^a ^b Ganellin CR, Triggle DJ, Macdonald F (1997). Dictionary of pharmacological agents. CRC Press. p. 1003. ISBN 978-0-412-46630-4. Retrieved 26 November 2011.
^ ^a ^b Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 513. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.